To study the potential reduction of ALD diagnoses among screen positive males with an ABCD1 VUS, we used an ALD—specific analytical tool to re-examine the plasma VLCFA confirmatory test interpretations. This evidence concerns the gene ABCD1 and X-linked adrenoleukodystrophy.